You are here: Molecules\Osteoprotegerin\References:

References to Osteoprotegerin (OPG, Osteoclastogenesis inhibitory factor, OCIF)

Back to Osteoprotegerin (OPG, Osteoclastogenesis inhibitory factor, OCIF)
  • Aubin JE, Bonnelye E. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Medscape Womens Health. 2000 Mar;5 (2):5
  • Aukrust P, Froland SS, Muller F, Godang K, Bollerslev J, Ueland T. Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis. Eur J Endocrinol. 2001 Dec;145 (6):685-90
  • Boyle WJ, Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997 Apr 18;89 (2):309-19
  • Dupuy AM, Cristol JP, Thuan Dit Dieudonne JF, Avignon A, Mariano-Goulart D, Piot C, Sultan A. Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients. Diabetes Care. 2007 Nov;30 (11):2934-9
  • Faxvaag A, Feuerherm AJ, Borset M, Seidel C, Sundan A, Leistad L, Ostensen M. Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis. Scand J Rheumatol. 2001;30 (4):229-34
  • Garshick E, Stashenko P, Battaglino RA, Tun CG, Williams S, Jain N, Nguyen HP, Morse LR. Age and motor score predict osteoprotegerin level in chronic spinal cord injury. J Musculoskelet Neuronal Inter. 2008 Jan-Mar;8 (1):50-7
  • Golledge J, Ketheesan N, Norman P, Karan M, McCann M, Moran CS. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation. 2005 Jun 14;111 (23):3119-25
  • Golledge J, McCann M, Mangan S, Lam A, Karan M. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke. 2004 Jul;35 (7):1636-41
  • Hofbauer LC. Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. Eur J Endocrinol. 1999 Sep;141 (3):195-210
  • Kalhs P, Pietschmann P, Fialka-Moser V, Bieglmayer C, Grampp S, Kudlacek S, Mitterbauer M, Fureder W, Kerschan-Schindl K. Bone metabolism in patients more than five years after bone marrow transplantation. Bone Marrow Transplant. 2004 Sep;34 (6):491-6
  • Nellemann B, Nielsen S, Rasmussen LM, Mogensen CE, Schmitz O, Gormsen LC, Dollerup J. Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria. Diabetes Care. 2007 Dec;30 (12):3122-4
  • Pavelka K, Kraus VB, Prochazka B, Gatterova J, Machacek S, Olejarova M, Vytasek R, Vilim V. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis Cartilage. 2001 Oct;9 (7):612-8
  • Simonet WS, Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998 May 1;12 (9):1260-8
  • Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res. 1999 Apr;14 (4):518-27
  • Zauli G, Capitani S, Celeghini C, Fabris B, Candido R, Consoli A, Pandolfi A, Corallini F, Secchiero P. An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. Am J Pathol. 2006 Dec;169 (6):2236-44

Shopping cart

Your cart is empty.